Association between the G175a and rs12325817 polymorphisms in the phosphatidylethanolamine n-methyltransferase gene and susceptibility to nonalcoholic fatty liver disease

World Chinese Journal of Digestology

Volumn 19, Issue 29, 2011, Pages 3035-3039

  Tang, Hua ^a   Wang, Xu Xia ^a   Zhao, Shu Guang ^a   Wang, Jing Jie ^a   Zhang, Chao ^a   Lu, Wang ^a   Li, Hui Yan ^a   Wen, Qin Sheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene polymorphisms; Nonalcoholic fatty liver disease; Phosphatidylethanolamine n methyltransferase gene

Indexed keywords

EID: 84922686303     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114: 147-152
2. Zhou YJ, Li YY, Nie YQ, Yang H, Zhan Q, Huang J, Shi SL, Lai XB, Huang HL. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol 2010; 25: 772-777
3. Chinese Source
4. Song J, da Costa KA, Fischer LM, Kohlmeier M, Kwock L, Wang S, Zeisel SH. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J 2005; 19: 1266-1271
5. Chinese Source
6. Xu X, Gammon MD, Zeisel SH, Lee YL, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J. Choline metabolism and risk of breast cancer in a population-based study. FASEB J 2008; 22: 2045-2052
7. Koek GH. [Treatment of non-alcoholic fatty liver disease]. Ned Tijdschr Geneeskd 2011; 155: A3181
8. Oe K, Ochi T, Hayase Y, Saibara T. [Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD)]. Nihon Rinsho 2011; 69 Suppl 1: 406-409
9. Dowman JK, Armstrong MJ, Tomlinson JW, Newsome PN. Current therapeutic strategies in non-alcoholic fatty liver disease. Diabetes Obes Metab 2011; 13: 692-702
10. Saibara T, Ono M. Phosphatidylcholine could have a key role in the pathogenesis of steatohepatitis - Reply. J Hepatol 2007; 47: 869-870
11. Zhu X, Song J, Mar MH, Edwards LJ, Zeisel SH. Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline. Biochem J 2003; 370: 987-993
12. Tarquini R, Lazzeri C, Boddi M, Marra F, Abbate R, Gensini GF. [Non-alcoholic fatty liver disease: a new challenge for cardiologists]. G Ital Cardiol (Rome) 2010; 11: 660-669
13. Dong H, Wang J, Li C, Hirose A, Nozaki Y, Takahashi M, Ono M, Akisawa N, Iwasaki S, Saibara T, Onishi S. The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J Hepatol 2007; 46: 915-920
14. da Costa KA, Kozyreva OG, Song J, Galanko JA, Fischer LM, Zeisel SH. Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J 2006; 20: 1336-1344
15. Zeisel SH. People with fatty liver are more likely to have the PEMT rs7946 SNP, yet populations with the mutant allele do not have fatty liver. The FASEB Journal 2006; 20: 2181-2182